Drug studies in animals
Last updated: 2025 Mar 18
Total hit(s): 1042
S.No.
1
39635731
Nationwide seroprevalence of SARS-CoV-2 Delta variant and five Omicron sublineages in companion cats and dogs in the USA: insights into their role in COVID-19 epidemiology.
Emerg Microbes Infect
2025 Dec
5.84
1
2
40028815
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.
Hum Vaccin Immunother
2025 Dec
4.7
1
3
39837378
In-vivo implementation of the HPTLC methodology to rat plasma for the concurrent determination of a novel combination therapy for the management of COVID-19 (favipiravir and nitazoxanide).
Anal Biochem
2025 May
1
4
40023068
Exploring the therapeutic potential of HAPC in COVID-19-induced acute lung injury.
Phytomedicine
2025 Apr
7.2
1
5
40058641
Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Severe Cases: A Single-Center Study from Japan.
J Infect Chemother
2025 Mar 7
1.59
1
6
40038251
LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment.
Nat Commun
2025 Mar 4
11.8
1
7
40038712
Frequency of IgE antibody response to SARS-CoV-2 RBD protein across different disease severity COVID19 groups.
Virol J
2025 Mar 4
2.45
1
8
39970838
Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2 infection in mice.
Biochem Biophys Res Commun
2025 Mar 19
2.73
1
9
39837387
Intranasal liposomal remdesivir induces SARS-CoV-2 clearance in K18-hACE2 mice and ensures survival.
J Control Release
2025 Mar 10
15.5
1
10
39907512
A Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARS-CoV-2.
Immunol Rev
2025 Mar
1
11
39921982
Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice.
Vaccine
2025 Feb 7
3.31
1
12
39895416
Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice.
FEBS Open Bio
2025 Feb 3
2.02
1
13
40019854
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease.
J Med Chem
2025 Feb 28
6.26
1
14
40000611
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants.
Signal Transduct Target Ther
2025 Feb 26
- n/a -
1
15
39988470
Novel Sulfonamide-Sydnone Hybrids: Complementary Insight into Anti-Inflammatory Action, Anti-SARS-CoV-2 Activity, Human Serum Albumin Interaction, and in silico Analysis.
ChemMedChem
2025 Feb 23
5.5
1
16
39987727
Retraction notice to "Differential detection of SARS-CoV-2 variants and influenza A viruses utilizing a dual lateral flow strip based on colloidal gold-labeled monoclonal antibodies" [Int. J. Biol. Macromol. 280P4 (2024) 136067].
Int J Biol Macromol
2025 Feb 21
4.94
1
N/A
17
39960599
Two adolescents with frequently relapsing nephrotic syndrome newly diagnosed after SARS-CoV-2 vaccination: case report and literature review.
CEN Case Rep
2025 Feb 17
1.5
1
18
39948424
Intratumoral administration of mRNA COVID-19 vaccine delays melanoma growth in mice.
Sci Rep
2025 Feb 13
4.12
1
19
39948345
Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology.
NPJ Vaccines
2025 Feb 13
4.98
1
20
39943808
SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation.
ACS Nano
2025 Feb 12
13.7
1
21
39928242
Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands.
Adv Ther
2025 Feb 10
3.2
1
22
39941049
Subgenomic RNA Detection in SARS-CoV-2 Assessing Replication and Inactivation Through Serial Passages, RT-qPCR, and Electron Microscopy.
Int J Mol Sci
2025 Feb 1
4.21
1
23
39908775
Porcine epidemic diarrhea coronavirus infection activates caspase-8 to enhance innate immunity by blocking CYLD-mediated deubiquitination of RIG-I.
Virology
2025 Feb 1
2.819
1
24
39742790
Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants.
Biochem Biophys Res Commun
2025 Feb
2.73
1
25
39789633
Interplay of swine acute diarrhoea syndrome coronavirus and the host intrinsic and innate immunity.
Vet Res
2025 Jan 9
1